ClinicalTrials.Veeva

Menu

Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk

University Hospitals (UH) logo

University Hospitals (UH)

Status and phase

Completed
Phase 4

Conditions

Knee Osteoarthritis

Treatments

Drug: celecoxib

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00194090
06-04-41

Details and patient eligibility

About

A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis

Full description

This is a randomizd, placbo-controlled, crossover trial comparing a single dose of celecoxib to placebo measuring the time to onset of acute pain in a paced 20-minute walk.

40 subjects will be enrolled

Enrollment

40 patients

Sex

All

Ages

45 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Knee osteoarthritis by ACR clinical criteria Pain of at least 40 mm by VAS at baseline

Exclusion criteria

Non-pregant, non-lactating Able to stop active arthritis medication for washout Cardiovascular risk factors Abnormal EKG -

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems